Tag: liposomal formulations

Recent advances in the treatment of neurodegenerative diseases based on GSH delivery systems

This review article explores the role of glutathione (GSH) in neurodegenerative diseases such as Parkinson’s and Alzheimer’s, focusing on the challenges of delivering GSH to the central nervous system due to its low stability and poor bioavailability. It highlights the potential of innovative GSH delivery systems—including prodrugs, nanoparticles, and liposomal

Read More »